Phaarmasia (BOM:523620) FFO


BOM:523620 Phaarmasia Ltd BOM:523620
62 GF Score
Price ₹98.74
GF Value ₹67.48
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Phaarmasia FFO?

FFO (Funds from operations) only applies to REITs.

BOM:523620
62GF Score
Phaarmasia Ltd BOM:523620
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Phaarmasia (BOM:523620) Overvalued in 2026?

Based on GuruFocus' analysis, Phaarmasia stock appears to be overvalued. The current stock price of ₹98.74 is trading 46.3% above its estimated GF Value™ of ₹67.48. GuruFocus considers Phaarmasia to be Significantly Overvalued.

Key valuation signals for BOM:523620:

  • FFO:
  • GF Value™: ₹67.48 vs. price of ₹98.74 (46.3% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BOM:523620 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phaarmasia Business Description

Address Plot No. 16, Phase III, IDA, Jeedimetla, Hyderabad, TG, IND, 500055
Phaarmasia Ltd is a pharmaceutical company based in India. It is engaged in the manufacturing of Oral Contraceptive Pills and Combipack with Iron tablets. It offers hormone and herbal products. The company operates in one operating segment namely, Manufacturing and sale of OCPs, and derives prime revenue from India.
62GF Score

Get the complete analysis for BOM:523620

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.74
Price
₹67.48
GF Value